Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
暂无分享,去创建一个
M. Sabatine | E. Braunwald | D. Morrow | S. Murphy | B. Scirica | M. Bonaca | R. O’Malley | P. Jarolím